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Atomistic design of microbial opsin-based
blue-shifted optogenetics tools
Hideaki E. Kato1,*,w, Motoshi Kamiya2,*, Seiya Sugo2, Jumpei Ito3, Reiya Taniguchi1, Ayaka Orito3, Kunio Hirata4,
Ayumu Inutsuka5, Akihiro Yamanaka5, Andre´s D. Maturana3, Ryuichiro Ishitani1, Yuki Sudo6, Shigehiko Hayashi2
& Osamu Nureki1
Microbial opsins with a bound chromophore function as photosensitive ion transporters and
have been employed in optogenetics for the optical control of neuronal activity. Molecular
engineering has been utilized to create colour variants for the functional augmentation
of optogenetics tools, but was limited by the complexity of the protein–chromophore inter-
actions. Here we report the development of blue-shifted colour variants by rational design at
atomic resolution, achieved through accurate hybrid molecular simulations, electrophysiology
and X-ray crystallography. The molecular simulation models and the crystal structure reveal
the precisely designed conformational changes of the chromophore induced by combinatory
mutations that shrink its p-conjugated system which, together with electrostatic tuning,
produce large blue shifts of the absorption spectra by maximally 100 nm, while maintaining
photosensitive ion transport activities. The design principle we elaborate is applicable to other
microbial opsins, and clarifies the underlying molecular mechanism of the blue-shifted action
spectra of microbial opsins recently isolated from natural sources.
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P
hotoreceptor proteins have been widely utilized as biotech-
nological tools in the genetic techniques to optically control
cell activities, called optogenetics1,2. One of the major
families of such protein tools consists of microbial opsins,
membrane proteins characterized by seven transmembrane
helices that bind a chromophore, retinal, to a lysine residue of
the protein through a protonated Schiff base linkage, RPSB3.
Rhodopsins, the opsin–retinal complexes, exist in a wide variety
of microbial species and serve in various physiological functions,
such as photosynthesis and phototaxis. In optogenetics, some
microbial opsins such as channelrhodopsins (ChRs) and
archaerhodopsin-3 (AR3), which function as light-sensitive ion
transporters, are heterologously expressed in animal neurons to
excite and silence them, and consequently to control animal
behaviours by illumination with light4–9.
Similar to the fluorescent proteins utilized in cell visualization,
the functionalities of the microbial opsins in optogenetics
have been diversified through genomic searches for analogous
light-sensitive ion transporters and molecular engineering10.
Colour variants, which enable colour-regulated dual-light
activations of ion transporters, exemplify such augmentations
of the functionality11–17. As seen in the visual receptors and
various microbial rhodopsins, and demonstrated in an extensively
engineered retinal-binding protein18, the absorption maximum of
the RPSB chromophore can be tuned in a wide range of the
visible region through protein–chromophore interactions.
The strategy for developing the colour variants has involved
extensive searches and screens, which in general, require vast
resources and would quickly reach a limit for further extension due
to combinatorial explosion. Alternatively, a rational approach of
molecular engineering based on solid design principles could
circumvent this problem. Nevertheless, a rational approach to
create colour variants of microbial rhodopsins with large spectral
shifts has remained challenging, even though their three-dimen-
sional structures are available. For example, point mutations at 13
positions introduced in phoborhodopsin (lmax¼ 497 nm), guided
based on the X-ray crystallographic structure19–22 to make the
sequential and spatial alignments of the mutated residues in the
binding pocket identical to those of a largely red-shifted microbial
opsin, bacteriorhodopsin from Halobacterium salinarum (HsBR,
lmax¼ 568 nm), a light-driven proton pump, shifted the absorption
maximum by 30nm, which is only 40% of the overall 70 nm
spectral shift of the native proteins23. This observation indicated
that the creation of colour variants requires precise structural design
at atomic resolution based on physicochemical considerations.
In the present study, we rationally develop largely blue-shifted
colour variants of microbial rhodopsins, using theoretical
chemistry, biochemistry, electrophysiology and X-ray crystal-
lography. We formulate atomistic design principles of synergetic
point mutations that induce conformational changes of the
chromophore, consequently leading to a large spectral shift.
Together with a point mutation that alters the electrostatic
environment, we successfully obtain—with only double to
quadruple point mutations—colour variants of a number of
microbial rhodopsins exhibiting remarkable spectral shifts of up to
100nm. This is twice as large as the maximum shift previously
obtained by molecular engineering, while maintaining the
photosensitive ion transport activities. The present study demon-
strates that highly resolved atomistic design provides a strong
basis for the production of colour variants through minimal
modification that is universally applicable to analogous proteins.
Results
Atomistic design principle. We first designed colour variants
of two of the most widely used optogenetics tools, ChR and
AR3, based on the available crystal structures of C1C2
(ref. 24), a chimeric protein of ChRs that has been utilized in
optogenetics25–27, and HsBR, as HsBR shares high sequence
similarity with AR3. In the native proteins of C1C2 and AR3, as
well as those of microbial rhodopsins with presently available
X-ray crystallographic structures, the methyl groups at positions 1
and 5 (C16, C17, and C18 methyl groups; see Fig. 1a) in the
b-ionone ring of the chromophore are recognized by cavities
created by the well-conserved residues of the binding pocket,
which maintain the orientation of the ring alignment in the same
plane as the polyene chain (Fig. 1b–g, Supplementary Fig 1 and
Supplementary Table 1). Accordingly, the planar conformation at
the C6–C7 bond, which connects the b-ionone ring with the
polyene chain part, is fixed.
We introduced point mutations that enforce torsion around
the C6–C7 bond from planarity in C1C2 and AR3 (Fig. 2), to
shrink the p-conjugation and consequently to produce blue shifts
of their absorption spectra3,28 (Supplementary Fig. 2). The C6–C7
bond can be easily twisted, that is, the potential energy curve
along the torsional coordinate is flat29–31 (Supplementary Fig. 2).
Theoretical studies30–35 have suggested that the significant
torsion around the C6–C7 bond by B30 in bovine rhodopsin
(Supplementary Fig. 1 and Supplementary Table 1) is an
important factor determining its absorption spectrum36.
The mutation-enforced torsion around the C6–C7 bond was
designed as follows (see also Fig. 2). First, the b-ionone ring was
rotated byB140, thus forming the 6-s-cis conformation. In this
rotated conformation, the C18 methyl group, instead of the C16
methyl group before the rotation, plunges into the cavity between
Pro266 and Phe269 in C1C2. The rotation also moves the C17
methyl group to the cavity where the C18 methyl group was
located before the rotation. These two methyl groups therefore
avoid steric conflict in the binding pocket, by the rotation of the
b-ionone ring. On the other hand, the rotation induces the steric
overlap of the C16 methyl group and the moiety at position 2 in
the b-ionone ring with the side chains of Thr198 in C1C2. To
remove the steric overlap, we replaced the amino acid with
glycine, which has a smaller side chain. In the case of HsBR,
Met118 and Ser141, which are located in the region correspond-
ing to Thr198 in C1C2, are replaced with alanine and glycine. In
addition, the rotation creates a cavity at Gly202 in C1C2 (Gly122
in HsBR), which is filled by the C17 methyl group in the b-ionone
ring before the rotation. Therefore, we replaced the glycine with
alanine (and valine for AR3) to fill the created cavity. Overall, the
double and triple mutations of the amino acids around the
b-ionone ring described above were introduced to stabilize its
rotated conformation in the binding pocket. Further shifts due to
electrostatic modulation were also introduced into AR3 by the
rotation of the b-ionone ring and an additional mutation, A225T.
Generally speaking, a more negative (positive) field around the
protonated Schiff base (the b-ionone ring) side of the chromo-
phore shifts the absorption maximum to a shorter wavelength3,28.
In the case of AR3, therefore, Ala225 (Ala215 in HsbR depicted in
Fig. 2b) in the vicinity of the protonated Schiff base was replaced
by threonine, to induce a further blue shift37–40. Moreover, the
p-conjugation end of retinal and the neighbouring hydroxyl
group of S151 (S141 in HsBR) in native AR3 are separated by the
rotation of the b-ionone ring (Fig. 2b), giving rise to an additional
blue-shift by weakening the electrostatic interaction.
Structural models of C1C2 (Fig. 2a) and HsBR (Fig. 2b) were
obtained by free energy geometry optimizations with the QM/
MM RWFE-SCF method41,42 (Fig. 2 and Supplementary Table 2).
Free energetically stable structures with strongly twisted
conformations of the C6–C7 bond were determined for the
designed mutants, T198G/G202A of C1C2 and M118A/G122A/
S141G/A215T of HsBR (Fig. 2 and Supplementary Table 2).
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The C6–C7 bond in the C1C2 mutant exhibited significant
torsion, by  27.7. In the quadruple mutant of HsBR, the C6–C7
bond is further twisted to  45.1, and thus a larger spectral shift
was predicted (Supplementary Fig. 2).
The QM/MM free energy calculation showed that the
free energy of the twisted 6-s-cis conformation is lower by
 1.1 kcalmol 1 than the planar 6-s-trans one in the C1C2
mutant, indicating that the twisted 6-s-cis conformation is more
stable. A small contribution of the chromophore–protein
interaction (0.9 kcalmol 1) to the free energy difference
indicated that the binding pocket was successfully designed to
accommodate the twisted 6-s-cis chromophore without a
significant increase in the steric conflict, despite the large change
in its molecular shape.
Absorption spectra and functions of C1C2 and AR3. To verify
the design principle, we measured the absorption spectra and ion
transport activities of the designed mutant proteins. First, we
expressed and purified the mutants, and measured their absorp-
tion spectra. The T198G/G202A mutant of C1C2 (C1C2GA)
showed a blue-shifted absorption spectrum (lmax¼ 455 nm) as
compared with that of wild-type C1C2 (C1C2WT; lmax¼ 476
nm; Fig. 3a), which was well predicted by the torsion at the
C6–C7 bond (Supplementary Table 2 and Supplementary Fig. 2).
Notably, the mutant spectrum lacked the spectral shoulder that
appears at B447 nm in the C1C2WT spectrum. The spectral
shoulder is suggested to represent a vibrational fine structure that
is also observed in the absorption spectrum of phoborhodopsin
(also known as sensory rhodopsin II, SRII), a microbial rhodopsin
functioning as a phototaxis receptor, and experimentally
examined by Takahashi et al.43. The disappearance of the
vibrational fine structure is explained well by the rotation of the
b-ionone ring.
As suggested by Takahashi et al.43, the possible causes for the
lack of fine structure are a wider distribution of the Franck–
Condon vibrational modes in the excited state and/or a ground-
state conformational heterogeneity inducing a larger electrostatic
perturbation. Although there is no evidence that the distortion
around the C6–C7 bond in the 6-s-cis conformation increases the
ground-state conformational heterogeneity, the Franck–Condon
vibrational distribution in the excited state is expected to be wider
in the distorted conformation, since the rotation around the
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Figure 2 | Structural models of blue-shifted mutants. Structural models of



































































Figure 1 | Opsin and chromophore structures of C1C2 and HsBR. (a) Chemical structure of the chromophore, RPSB, and its atom numbering. (b–d)
Protein structure of C1C2 (PDB 3UG9). Overall structure (b), and close-up views of the chromophore binding pocket around the b-ionone ring of the all-
trans retinal (ATR) in licorice (c) and van der Waals (vdW) (d) representations. (e–g) Protein structure of HsBR (PDB ID: 1C3W). Overall structure (e), and
close-up views of the chromophore binding pocket around the b-ionone ring of ATR in licorice (f) and vdW (g) representations.
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more steeply than that at the planar angle, as shown in
Supplementary Fig. 2.
Another possible source for the enhancement of the vibrational
fine structure is the contribution of the second excited (S2) state,
which lies close to the optically allowed first excited (S1) one38,43.
In this case, the disappearance of the shoulder in the mutant is
also well explained by the rotation of the b-ionone ring, which
separates the energy levels of the S1 and S2 states (Supplementary
Fig. 2), and thus is expected to weaken the absorption intensity of
the S2 state by intensity borrowing from the S1 state, through
vibronic coupling.
Alternatively, another possible origin of the spectral shoulder
in the C1C2WT spectrum is the contribution of the twisted 6-s-cis
conformation of the retinal chromophore, which may co-exist
with the planar 6-s-trans conformation in C1C2WT, since the
wavelength of the spectral shoulder coincides with the absorption
maxima of the C1C2GA mutant. However, from a structural
point of view, the X-ray crystallographic structure of C1C2WT24
clearly shows that the 6-s-trans conformation is precisely
recognized by the surrounding protein side chains (Fig. 1), and
the 6-s-cis conformation in the binding pocket of C1C2WT would
give rise to steric clash between the methyl group at the 16th
position of the retinal chromophore and the side chain of Thr198.
In fact, the present mutation of T198G in the C1C2GA mutant
was designed to avoid the steric clash, by reducing the molecular
volume of the side chain of Thr198. Other microbial rhodopsins
with available structures also possess relatively bulky side
chains at the corresponding positions, and were thus found to
bind the chromophore in the 6-s-trans conformation as well
(see Supplementary Fig. 1). C1C2WT is therefore suggested to
exclusively bind the 6-s-trans conformation, as observed in the
other microbial rhodopsins, and thus the spectral shoulder
at 450 nm is unlikely to be due to a mixture of the 6-s-cis and
6-s-trans conformations.
Decomposition of the absorption spectra of C1C2WT and
C1C2GA into the spectral components also showed that the
spectral width of the component corresponding to the shoulder at
450 nm in the spectrum of C1C2WT is significantly narrower,
and is approximately half of that of C1C2GA (Supplementary
Fig. 3 and Supplementary Table 3), thus disfavouring the
possibility of the mixture of the 6-s-cis and 6-s-trans conforma-
tions in C1C2WT as well.
The absorption maximum of purified AR3, lmax¼ 552 nm, was
also drastically shifted to 454 nm by mutations at only three
positions, M128A/G132V/A225T (Fig. 3b). The spectral shift by
B100 nm of the mutant, which is still functional as a
photosensitive ion transporter (see below), is the largest ever
produced by the molecular engineering of rhodopsins so far, and is
twice as large as the largest one previously obtained for a triple
mutant of AR3, M128A/S151A/A225T (lmax¼ 500 nm)16. The
blue shift of the absorption spectrum can also be controlled by
point mutations at the designed positions. The M128A/G132A/
S151G/A225T and M128A/S151A/A225T mutants slightly reduced
the shifts to lmax¼ 471 and 491 nm, respectively (Supplementary
Table 4), and single and double mutants at those positions covered
the entire spectral range from 450–550 nm (Fig. 3b).
The remarkably large shifts are attained by the non-additive
synergy of the multiple mutations (Supplementary Table 4),
which clearly indicates the involvement of the atomistically
designed conformational changes induced by the coupled
mutations in the present study. Especially, the simultaneous
mutations at positions 128 and 132 (118 and 122 in HsBR,
respectively, depicted in Fig. 2b) gave rise to large synergetic
shifts. Moreover, the larger spectral shift of the M128A/G132A/
S151G/A225T mutant of AR3 than the shift of the T198G/G202A
mutant of C1C2 was predicted by the computational models, in
which the C6–C7 bond of the chromophore in the former is
significantly more twisted, as described above (Supplementary
Table 2 and Supplementary Fig. 2).
Next we examined the photosensitive ion transport activities of
the mutants. The C1C2GA mutant expressed in HEK293 cells
showed a slightly decreased, but still large photocurrent, as
compared with C1C2WT (Fig. 4a,b and Supplementary Fig. 4),
and exhibited a blue-shifted action spectrum consistent with its
absorption spectrum (Supplementary Fig. 5). C1C2GA, fused to
enhanced green fluorescent protein (EGFP), was well expressed in
mouse brain neurons (Supplementary Fig. 6), and showed a
significantly larger photocurrent (Fig. 4c,d) with light at a shorter
wavelength (445 nm) which, in contrast, gives rise to a smaller
photocurrent for C1C2WT (Supplementary Fig. 7). Indeed, the
optical activation of C1C2GA at 445 nm was sufficient to evoke
the neural spikes ensuring the proper function in neurons
(Fig. 4e). The photocurrents of the M128A/G132V/A225T
mutant of AR3 as well as the wild type were also examined, by
measuring the light-induced pH changes of the proteins
expressed in E. coli (Supplementary Fig. 8a). For the mutant,
we found a directionally inverted photocurrent, presumably due
to structural changes of the retinal chromophore such as the
rotation and/or a position shift of the b-ionone ring induced by
the mutations (to be reported and discussed further elsewhere).
The action spectra of the magnitude of pH change clearly showed
that, similar to the absorption spectra, the activity of the pH
change of the mutant is largely enhanced in the shorter
wavelength region around 450 nm and is significantly reduced



























Figure 3 | Absorption spectra of wild-type and colour variants of C1C2 and AR3. (a) Absorption of spectra of C1C2 and its mutant. (b) Absorption
spectra of AR3 and its mutants. The solutions of C1C2 contained 150mM NaCl, 5% glycerol, 0.05% DDM, 0.01% CHS and 50mM HEPES-NaOH (pH 7.0),
and those of AR3 contained 1M NaCl, 0.05% DDM and 50mM Tris-HCl (pH 7.0). Absorption maxima of AR3 are summarized in Supplementary Table 4.
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Crystal structure of the C1C2GA mutant. The atomistically
designed structural model that created the blue-shifted spectrum
was verified by solving the crystal structure of the C1C2GA
mutant. We expressed, purified and crystallized C1C2GA as
previously described24, and obtained yellow crystals in the lipidic
cubic phase under neutral pH conditions (pH 7.0; Fig. 5a,b). The
structure was determined by the molecular replacement method,
using the coordinates of C1C2WT (PDB ID: 3UG9)24, and
refined to 2.5 Å resolution (Table 1). As expected, the overall
structure of C1C2GA at pH 7.0 is almost identical to that of
C1C2WT at pH 6.0 (root mean squared deviation of 0.66Å over
all Ca atoms; Fig. 5b), except for the protonation states of
titratable groups, the amino-terminal (N-terminal) segment, and
the retinal-binding pocket.
Since the pH of the crystallization conditions was different, the
protonation states of several titratable residues were altered. We
found that the pH differences in the crystallization conditions
caused changes in the protonation states of Glu122, Asp40, His44
and/or His47. As a consequence, Glu122, located on the
extracellular side of TM2, lost the hydrogen bond with His173
(Supplementary Fig. 9). Since the side chain of Glu122 is
completely exposed to the bulk solvent, and the approximate pKa
of Glu122 calculated by PROPKA is 5.4, Glu122 may be
deprotonated under the neutral pH conditions. On the basis of
the crystal structure of C1C2WT at pH 6.0, a previous study
suggested that the hydrogen bond between Glu122 and His173
contributes to the formation of the intracellular channel gate 3.
Thus, we also assumed that Glu122 is deprotonated and exposed
to the bulk solvent, at least in the ground state under
physiological conditions, and its contribution to the formation
of the channel gate is smaller than previously expected.
The new feature of a binding site of an ion putatively assigned
to an endogenous Zn2þ appeared at the N-terminal segment in
the crystal structure under the neutral pH conditions (Fig. 5c and
Supplementary Fig. 10). The electron density map of C1C2GA
clearly showed the N-terminal 10 residues (PDYVFHRAHE),
which were disordered in the previous C1C2WT structure
(Supplementary Fig. 10). These N-terminal residues form a short
helix, which is located near the extracellular side of transmem-
brane helix 2 and extracellular loop 1 (Fig. 5b). Notably, Asp40,
His44 and His47 on the N-terminal helix coordinate a cation with
Asp142 on ECL1 (Fig. 5c and Supplementary Fig. 10). Owing to
the strong electron density and the tetrahedral coordination by
the His and Asp residues, this cation is most likely an endogenous
Zn2þ ion. As far as we know, this is the first evidence to suggest
that a putative Zn2þ ion is bound to the extracellular side
of ChR, and future studies will reveal the physiological role
of this ion.
At the binding pocket around the b-ionone ring, significant
changes in the electron density due to the mutations were
detected. In contrast to C1C2WT, the electron density of
C1C2GA clearly indicated the rotation of the b-ionone ring
(Supplementary Fig. 11). The space where the C17 methyl group
resides in C1C2WT becomes occupied by the methyl group of the
alanine residue introduced by the mutation, and instead the
C17 methyl group occupies the pocket formed by the threonine to
glycine mutation. The C5¼C6–C7¼C8 dihedral angle changes
from 177.7 to  31.4 (counterclockwise, positive), and conse-
quently the retinal configuration changes from 6-s-trans to 6-s-cis.
The atomic resolution structure is in good agreement with the
calculated model (Supplementary Fig. 12), and it strongly
supports the present design principle that the simultaneous
double mutations at positions 198 and 202 in C1C2 (118 and 122
in HsBR, respectively) induce the rotation of the b-ionone ring,
which leads to the significant blue-shift of the absorption
spectrum.
Applicability of the design principle. The molecular modelling
described above suggested that the design principle that guided
us to produce the blue-shifted colour variants of C1C2 and
AR3 is also applicable to other microbial rhodopsins as well.
Therefore, we next measured the absorption spectra of purified



































































445 nm 589 nm575 nm
500 ms
50 pA
500 1,000 1,500 2,000 0
Time (ms)
500 1,000 1,500 2,000
–200
1.5 2.512.7 6.2 2.1
546 nm
Figure 4 | Channel properties of the C1C2GA mutant in HEK cells and mouse neurons. (a) Photocurrents of C1C2WTand its GA mutant. Photocurrents
in C1C2-expressing HEK293 cells were measured at 16 different holding potentials. (b) The peak amplitudes of the photocurrents, normalized by the cell’s
input capacitance. Values are means and s.e.m. of 8–10 experiments. (c,d) The peak amplitudes (c) and photocurrents (d) of the C1C2GA mutant in
mouse neurons. (e) Current-clamp mode recording of C1C2GA, using light pulses at different wavelengths (100ms, 1–2Hz).
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bacteriorhodopsin from Haloquadratum walsbyi (HwBR) and
eubacterial rhodopsin from Gloeobacter violaceus (GR), engi-
neered based on the same design principle (Fig. 6a,b and
Supplementary Table 5). The mutants of HwBR, an orthologue of
AR3, showed a large blue shift similar to those of AR3. Fur-
thermore, a phylogenetically distant eubacterial GR from the
archaeal rhodopsins (Fig. 6c) also produced similar large blue
shifts by the mutations. The similarity of the spectral shifts,
together with the blue shifts obtained for the mutant ChR C1C2,
seen above, indicates the universality of the molecular mechanism
underlying the observed spectral shifts, and consequently the high
applicability of the rational approach across species separated by
long evolutionary distances (Fig. 6c).
Discussion
In the present study, colour variants with large spectral shifts
were created by altering the conformation of the chromophore,
which is a novel and different strategy from that of changing
the electrostatic environment surrounding the chromophore,
employed in previous studies of retinal-binding proteins18,23,44,45.
Extensive mutations are not appropriate for producing a large
spectral shift of the membrane proteins used as optogenetics
tools. The b-ionone ring of the chromophore resides in the very
hydrophobic membrane environment, and the introduction of
highly polar groups to change the electrostatic environment or
poorly packed groups in this region can easily damage the protein
stability. Any changes in the electrostatic environment around the
Schiff base group of the chromophore, which is situated in the
middle of an ion channel, are also limited for preserving the ion
transport functionalities, which require precise electrostatic
tuning of the ion channels in the hydrophobic membrane
environment. In fact, although a directed evolution experiment
recently showed that a few combinatory mutations in GR
generate blue shifts of absorption spectra by maximally 80 nm,
the mutations that created shifts of more than 50 nm were found
to abolish the proton pump activity46. The high spatial precision
of the atomistic design in the present study minimized
unnecessary modifications that could lead to loss of ion trans-
port function. Therefore, it was possible to design the synergetic
combinatory mutations in the highly packed hydrophobic region
around the b-ionone ring, to give rise to the well-controlled
conformational changes that remarkably alter the absorption
spectra yet maintain the photosensitive ion transport activities.
The use of modifications in the region far from the ion channel
also leaves room for further engineering to change other
properties, such as channel characteristics and protein stability.
The present atomistic design driven by the physicochemical
principle successfully identified the universality of molecular
recognition for ligand binding, which can be exploited to
extensively create blue-shifted colour variants of analogous




























Figure 5 | X-ray crystallography of the C1C2GA mutant. (a) Photographs
of C1C2WT (left) and C1C2GA mutant (right). (b) Side view of the
superimposed structures of C1C2WT (grey) and C1C2GA (green). The
regions around the putative Zn2þ -binding site and the b-ionone ring of the
retinal molecule are highlighted in the blue and yellow rectangles,
respectively. The N-terminal region only seen in C1C2GA is coloured blue.
The putative Zn2þ , depicted by a cpk model, is coloured pink, and retinal
molecules, depicted by stick models, are coloured grey (C1C2WT) and
yellow (C1C2GA), respectively. (c) Magnified view of the blue highlighted
region in b. Pink spheres and black dashed lines represent Zn2þ and
hydrogen bonds, respectively. (d,e) Magnified views of the yellow
highlighted region in b, in which the retinal molecules and surrounding
residues are shown as stick models (d) and cpk models (e).
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*Highest-resolution shell is shown in parentheses.
wCC1/2 values were calculated using the programme XDS.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8177
6 NATURE COMMUNICATIONS | 6:7177 | DOI: 10.1038/ncomms8177 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
sheds light on the underlying molecular mechanism of the
significantly blue-shifted action spectra of the recently
isolated ChRs from Platymonas subcordiformis and Tetraselmis
cordiformis (PsChR and TcChR, lmax¼ 430–40 nm)14,17. We
aligned the sequences of several ChRs, including C1C2WT,
C1C2GA, PsChR and TcChR, and found that among all known
ChRs, only C1C2GA, PsChR and TcChR simultaneously have
glycine residues at position 198 and alanine residues at position
202 (Supplementary Fig. 13). This finding strongly suggests that
the blue-shifted absorption spectra of PsChR and TcChR
originated from the rotated b-ionone ring of the retinal
chromophore, as in C1C2GA. It is noteworthy that no
structures of microbial rhodopsins from natural sources that
bind the retinal chromophore in the 6-s-cis conformation have
been found (see Supplementary Fig. 1). The hypothesis of the 6-s-
cis conformation of the retinal chromophores in PsChR and
TcChR may therefore provide novel insight into the architectures
of the naturally evolved microbial rhodopsins. The evolutionary
view also supports our physicochemical design principle to create
the blue-shifted optogenetics tools.
Previously, a triple mutant, M128A/S151A/A225T, of AR3
with a blue shift by B50 nm (lmax¼ 500 nm) was heuristically
found, and the shift was tentatively interpreted to be attributed to
rotation of the b-ionone ring based on QM/MM modelling16.
However, much more drastic blue shifts of up to 100 nm with a
threefold larger synergetic effect (Supplementary Table 4) were
induced by the simultaneous double mutations at positions 128
and 132 (198 and 202 in C1C2), which were absent in the
previous mutant and were first introduced in the present study.
The observation of the significantly larger shifts indicates that the
simultaneous double mutations at positions 128 and 132 are
required for the controlled rotation of the b-ionone ring, which
was verified by the QM/MM free energy calculation and the X-ray
crystallography in the present study. However, the moderate blue
shift without the simultaneous double mutations in the previous
study is not due to the rotation of the b-ionone ring, but to
uncontrolled structural changes.
In optogenetics applications, the colour variants developed in
the present study can be employed for simultaneous neural
activation and activity imaging47–50 in addition to dual
activation11–17. The absorption spectra blue-shifted to
B450 nm with the steep decay in the red edges significantly
widens the no-absorbance region that can be utilized for the
activation of red fluorescent proteins for imaging of calcium ions,
and thus are expected to improve and augment the simultaneous
manipulation/imaging techniques.
The mechanistic generality underlying the design of the blue-
shifted mutants established in the present study permits the
application of the same design principle for the development of
colour variants of other microbial rhodopsins. Although the
applicability of equivalent mutants of various microbial rhodop-
sins as optogenetics tools is not trivial, since the mutations can
affect other properties in vivo such as expression level, protein
stability and photocurrent, the present set of mutations represents
a promising first step toward the creation of mutants with
significant spectral shifts, which can subsequently be subjected to
further maturation for the development of colour variants
working as optogenetics tools.
The present study demonstrated that molecular conforma-
tional design at atomic resolution, achieved by accurate hybrid
molecular simulations and high resolution X-ray crystallography,
can create novel variants that are unattainable by conventional
rational design. The atomistic design will be a powerful approach
to engineer various biotechnological protein tools with complex
functionalities, which require precise control of the molecular
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Figure 6 | Absorption spectra and phylogenetic tree of HwBR and GR. (a,b) Absorption spectra of wild-type and colour variants of HwBR (a) and GR (b).
The spectra obtained in the solutions containing 1M NaCl and 0.05% DDM, with pHs adjusted to 7.0 with 50mM Tris-HCl. (c) Phylogenetic tree of
microbial opsins.
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Methods
Molecular simulations. HsBR was used as the model system for AR3 and HwBR,
as in the previous study16. The X-ray crystallographic structure of HsBR by
Luecke et al.20 (PDB ID: 1C3W) was employed for the initial structure. For the
C1C2 chimera, the recently solved X-ray crystallographic structure by Kato et al.24
(PDB ID: 3UG9) was used. A monomer taken from the X-ray structure of each
protein was embedded into a POPC bilayer, and then filled with water molecules
and counter ions to neutralize the systems. The numbers of POPC molecules were
125 for HsBR and 118 for C1C2, and those of water molecules were 11,160 for
HsBR and 19,757 for C1C2. The titration states of Asp95, Asp115 and Glu204 in
HsBR, and those of Glu122, Glu129, Glu136 and Asp195 in C1C2 were set to be
protonated. These systems were equilibrated by classical molecular dynamics (MD)
calculations. The G122V/M126A/S141G/A215T mutant of HsBR and the T198G/
G202A mutant of C1C2 with the retinal protonated Schiff base (RPSB) in the
6-s-cis form were also modelled from their corresponding intact proteins. The force
field parameters were obtained from the CHARMM22/CMAP parameter set51–55.
For RPSB, the previously determined parameters were employed29,38,56–60. Long-
range electrostatic interactions were treated with the particle mesh Ewald method.
All MD simulations were performed with the NAMD programme package61.
The equilibrated systems were further refined by the QM/MM RWFE-SCF
method41, which combines QM/MM calculations and classical MD simulations.
Thus, this method is capable of removing possible structural artifacts of the
modelled mutations through sufficient thermal relaxation by MD simulations,
while maintaining the high accuracy of the structural determination of the
electronically complex chromophore with QM treatment (Supplementary Fig. 14).
The QM region consists of the side chain of Lys216 covalently binding RPSB with a
boundary at Cb–Cg, Arg82 at Cb–Cg, Asp85 at Ca–Cb and Asp212 at Ca–Cb, and
three water molecules in the binding pocket (Wat401, Wat402 and Wat406) for
HsBR. These QM atoms in HsBR were kept fixed in all of the classical MD
trajectory calculations (that is, even in equilibration runs) to maintain the
hydrogen bond network in this region. RPSB covalently bound to Lys296, with a
boundary at Cd-Ce, was chosen as the QM region for C1C2. Hydrogen atoms were
employed for the link atoms capping the QM–MM boundaries. The B3LYP
functional was used for the QM/MM calculation in the QM/MM RWFE-SCF
geometry optimization. We employed the 6–31þG** basis set for the carboxylate
anion groups and water molecules in HsBR, 6–31G for the terminal CH3 groups
involving link atoms, and 6–31G** for the others. In each cycle of sequential
samplings by the classical MD simulations in the QM/MM RWFE-SCF free energy
geometry optimizations, equilibrium simulations of 3 ns for HsBR and 4 ns for
C1C2 were obtained, and the conformational samples from the last 2 ns for both
HsBR and C1C2 were employed for the statistical averages. The sufficiently
reweighted averages41 were confirmed at the last steps of the free energy
optimizations. The convergence criterion of the geometry optimization of the free
energy surface for HsBR was set to 1.0 10 3 Hartree/Bohr for the largest
component of the gradient of the QM region. For C1C2, the convergence criterion
was decreased to 0.5 10 4 Hartree/Bohr, to improve the accuracy of the free
energy calculation (see below). The QM/MM calculations were performed with a
modified version of GAMESS62.
To evaluate the relative stability of the 6-s-conformers, the free energy
difference between the 6-s-trans and 6-s-cis conformers of the T198G/G202A
mutant of C1C2 was calculated, according to the protocol described previously42.
The optimized structure of the 6-s-trans T198G/G202A mutant of C1C2 was
obtained by the same procedure as for the 6-s-cis conformer (Supplementary
Table 2). The QM–MM interaction component of the free energy difference
between these conformers was calculated using the Bennett acceptance ratio
method63 (BAR). In the free energy calculation, the structural interpolation of the
QM region was divided into the rotation around the C6–C7 bond by 140 and the
remaining part. The rotation part was further divided into 15 points (every 10
from 0 to 140), and the remaining part was also linearly divided into 10 points.
The atomic charges of the QM atoms were linearly changed during the C6–C7
rotation, and were kept fixed during the calculation in the remaining part. An MD
calculation for 40–60 ns was performed at each point, and 20,000 configurations
from the last 10 ns of the trajectory were used for the free energy difference
calculation with BAR. The total free energy difference between conformers was
obtained by adding the QM internal energy component of the free energy to the
QM–MM interaction component. The calculated free energy difference,
 1.1 kcalmol 1, comprised the internal contribution of  2.0 kcalmol 1
coming solely from the structural difference of the chromophore, and
0.9 kcalmol 1 from the interaction between the chromophore and the
surrounding proteins. The free energy difference from the vibrational zero-point
energy and the vibrational entropy was ignored, because the contribution is
expected to be minor and it exhibited poor convergence behaviour.
Protein expression and purification of C1C2WT and C1C2GA. The C1C2WT
and C1C2GA expression plasmids were constructed as previously described24.
Virus-infected Sf9 insect cells were cultured in Sf900II (Invitrogen) at 27 C for
24 h, and then the temperature was reduced to 20 C. Cells were harvested 72 h
after infection. The pellets were disrupted by two passages through a microfluidizer
at 15,000 p.s.i., and were resuspended in a buffer containing 300mM NaCl, 50mM
Tris-HCl, pH 8.0, 5% glycerol and 0.1mM phenylmethylsulfonyl fluoride. The
preparation of the crude membranes and the purification of the proteins were
performed essentially according to the previously described methods24. Briefly, the
cell membranes were solubilized by n-dodecyl-b-D-maltoside (DDM) with
cholesteryl hemisuccinate (CHS) and purified by chromatography on Ni2þ affinity
and size-exclusion columns. Peak fractions were collected, concentrated to
B10mgml 1 and stored at  80 C until use.
Crystallization of C1C2GA. C1C2 was mixed with monoolein (Sigma) in a 2:3
protein to lipid ratio (w/w). Aliquots (100 nl) of the protein-LCP mixture were
spotted on a 96-well sandwich plate and overlaid by 1 ml of precipitant solution by
the crystallization robot, mosquito LCP (TTP LabTech). Crystals were obtained in
28% (w/v) PEG500DME, 100mM HEPES-NaOH, pH 7.0, 220mM Li2SO4 and
10mM ATP. All crystals were incubated for 2–3 weeks in the dark. They were
harvested using micromounts (MiTeGen), and were flash-cooled in liquid nitrogen
without any additional cryoprotectant.
C1C2 electrophysiology in HEK cells. HEK293 cells were cultured in DMEM,
supplemented with 10% fetal bovine serum, on poly-lysine-coated glass-bottom
culture dishes (Matsunami). The cells were transfected with 1 mg of the expression
plasmid for GFP-tagged C1C2WT or GFP-tagged C1C2GA, using Fugene6 (Pro-
mega). After 30 h, the cells were placed under an inverted microscope (IX-71,
Olympus), in a bath solution containing 140mM NaCl, 1mM CaCl2, 2mM MgCl2,
10mM HEPES and 5mM glucose (pH 7.4 with NaOH). A borosilicate patch
pipette (Harvard Apparatus) was filled with a pipette solution, containing
140mM KCl, 5mM EGTA, 2mM MgCl2 and 10mM HEPES (pH 7.2 with KOH).
Photocurrents were measured in the whole-cell configuration. The cells were
held at a membrane potential of  80mV and depolarized by 10mV voltage steps
up to þ 70mV. The light-induced currents were activated 200ms after the
depolarization step, by exposure to 442 nm or 470 nm light for 1,000ms, elicited
with an argon lamp coupled to a Polychrome V monochromator (Till Photonics).
Photocurrents were measured with an Axopatch 200B amplifier (Axon CNS,
Molecular Devices) connected to an A/D converter, Digidata 1440 (Axon),
controlled by the pClamp10.4 software (Axon). Absorption spectra of C1C2WT
and the mutant were determined by measuring the photocurrent at  80mV. Light
illuminations were shifted from 340 to 580 nm at 6-nm intervals. Photocurrent
intensities were corrected at each wavelength by the power density measured with
thermopile (SSC, Japan), and then normalized to the maximum photocurrent. The
maximum absorption was estimated at the graph peak. All data were analysed by
the pClampfit10.4 (Axon CNS) and Origin (Light Stone) software.
C1C2 electrophysiology in neurons. Seven-week-old C57BL/6J mice were injec-
ted with AAV-CMV-C1C2-2A-mCherry, and killed at 10 weeks of age. All AAV
vectors were produced using the AAV Helper-Free System (Agilent Technologies
Inc., Santa Clara, CA, USA), and purified basically according to the methods
previously reported64. In brief, HEK293 cells were transfected with a pAAV vector
plasmid that included a gene of interest, pHelper, and pAAV-RC (serotype DJ;
purchased from Cell Biolabs Inc., San Diego, CA, USA), using the standard calcium
phosphate method. Three days later, the transfected cells were collected and
suspended in artificial cerebrospinal fluid (124mM NaCl, 3mM KCl, 26mM
NaHCO3, 2mM CaCl2 1mM MgSO4, 1.25mM KH2PO4, 10mM D-glucose). After
four freeze–thaw cycles, the cell lysate was treated with benzonase nuclease (Merck,
Darmstadt, Germany) at 45 C for 15min, and centrifuged twice at 16,000g for
10min. The supernatant was used as the virus-containing solution. To measure the
titre of the purified virus dissolved in artificial cerebrospinal fluid, quantitative PCR
was performed. The virus was stored at  80 C in aliquots until use.
Surgeries for AAV injections were conducted under pentobarbital anaesthesia
(50mg kg 1, intraperitoneal), using a stereotaxic instrument (David Kopf
Instruments, Tujunga, CA, USA). Seven-week-old mice were injected
stereotaxically into the LHA with recombinant AAV-CMV-C1C2-2A-mCherry
(600 nl per injection, 2 1011 copiesml 1) with a glass micropipette and an air
pressure injector system (Pneumatic PicoPump; World Precision Instruments Inc.,
Sarasota, FL, USA). Injection sites were as follows: bregma 1.4mm, lateral
±0.7mm, ventral  5.0mm, for AAV-CMV-C1C2-2A-mCherry. Three weeks
after the AAV injection, the mice were killed to perform electrophysiological
experiments.
Brains were quickly isolated in ice-cold cutting solution, consisting of 280mM
sucrose, 2mM KCl, 10mM HEPES, 0.5mM CaCl2, 10mM MgCl2, 10mM glucose,
pH 7.4 with NaOH, bubbled with 100% O2, and immediately cut coronally into
350 mm-thick slices with a microtome (VTA-1200S, Leica Microsystems, Wetzlar,
Germany). Slices containing the LHA were transferred to an incubation chamber
filled with a physiological solution, containing 135mM NaCl, 5mM KCl, 1mM
CaCl2, 1mM MgCl2, 10mM HEPES, 10mM glucose, pH 7.4 with NaOH, bubbled
with 100% O2. The brain slices were then transferred to a recording chamber
(RC-27L, Warner Instruments, Hamden, CT, USA) on a fluorescence microscope
stage (BX51WI; Olympus, Tokyo, Japan). The fluorescence microscope was
equipped with an infrared camera (C2741-79; Hamamatsu Photonics, Hamamatsu,
Japan) for infrared differential interference contrast imaging and a CCD camera
(IK-TU51CU, Olympus, Tokyo, Japan). Neurons with mCherry fluorescence were
subjected to electrophysiological recordings. Recordings were performed with an
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Axopatch 200B amplifier (Molecular Devices LLC, Sunnyvale, CA, USA), using a
borosilicate pipette (GC150-10; Harvard Apparatus, Holliston, MA, USA) prepared
by a micropipette puller (P-1000; Sutter Instruments, Novato, CA, USA), filled with
an intracellular solution (4–10MO) consisting of 138mM K-gluconate, 8mM
NaCl, 10mM HEPES, 0.2mM EGTA-Na3, 2mM MgATP and 0.5mM Na2GTP,
pH 7.3 with KOH. During recordings, cells were superfused with the extracellular
solution at a rate of 1.6mlmin 1, using a peristaltic pump (Dynamax; Rainin
Instrument LLC, Oakland, CA, USA). For optogenetic stimulation, blue light
(475±17.5 nm, 2.5mW) was generated by a SPECTRA light engine (Lumencor).
The output signal was low-pass filtered at 5 kHz and digitized at 10 kHz. Data were
recorded on a computer through a Digidata 1322A A/D converter, using the
pClamp software (version 10; Molecular Devices). Traces were processed for
presentation using the Origin 9 software (Light Stone, Tokyo, Japan) and the
Canvas14 software (ACD Systems, Victoria, Canada).
Protein expression and purification of proton pump microbial rhodopsins. The
AR3, HwBR and GR expression plasmids were constructed as previously descri-
bed16. The mutant genes were constructed by PCR, using a QuikChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) as described previously65.
All constructed plasmids were analysed using an automated sequencer (ABI 3100)
to confirm the expected nucleotide sequences. The Escherichia coli DH5a strain
was used as the host for DNA manipulation.
For protein expression, transformed E. coli BL21(DE3) cells harbouring the
plasmid were initially grown at 30 C in 100ml LB medium, supplemented with
ampicillin (final concentration 50 mgml 1), and were directly inoculated into
2 l LB medium containing ampicillin. The cells were grown overnight on a rotary
shaker (MIR-220R, Sanyo Electric Co., Ltd., Osaka, Japan) at 18 C, in medium
containing 0.1% L-arabinose for AR3 and HwBR or 0.5mM isopropyl-b-D-
thiogalactoside for GR and 5 mM all-trans retinal. The cells were harvested by
centrifugation at 4 C, resuspended in buffer (50mM MES, pH 6.5) containing 1M
NaCl and disrupted by sonication or passage through a French press. The
preparation of crude membranes and the purification of proteins were performed
essentially by the previously described method66. In brief, the cell membranes were
solubilized by n-dodecyl-b-D-maltoside (DDM, Dojindo Lab, Kumamoto, Japan)
and purified by chromatography on an Ni2þ affinity column (GE Healthcare UK,
Amersham Place, England). When necessary, the samples were further purified by
anion exchange chromatography, as described previously66. The purified sample
was concentrated and buffer exchanged to buffer A (1M NaCl, 50mM Tris-Cl and
0.05% DDM, pH 7.0), using an Amicon Ultra filter (Millipore, Bedford, MA, USA).
The proton transport activity was measured by monitoring pH changes, using a
glass electrode. The E. coli cells expressing AR3 were harvested by centrifugation
(4,800g, 3min), and then were washed three times and resuspended in the solvent for
the measurement (100mM NaCl). A 7.5-ml portion of the cell suspension was kept
in darkness, and then illuminated with the output of a 100W Xe arc lamp (LM103,
Asahi Spectra, Japan) through a long-pass glass filter for 5min at a specific
wavelength region. The power of the light was controlled by ND filters (0.0625, 0.125,
0.25, 0.5, 1, 2.5 and 5W) to measure the power dependence of the pumping activities.
For the measurement of the action spectra, interference filters (FWHM¼ 10nm)
were used to obtain the light at specific wavelengths, by filtering the output of the
same Xe arc lamp. The photon flux of the light was measured by a calibrated multi-
channel detector (IRRAD-C2000þ , Ocean Optics, USA), and the initial slopes at the
specific wavelengths were measured to obtain the action spectrum.
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